Free hemoglobin induction of pulmonary vascular disease: Evidence for an inflammatory mechanism

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 4, 2012, Pages

  Buehler, Paul W ^a   Baek, Jin Hyen ^a   Lisk, Christina ^b   Connor, Ian ^b   Sullivan, Tim ^b   Kominsky, Douglas ^b   Majka, Susan ^b   Stenmark, Kurt R ^b   Nozik Grayck, Eva ^b   Bonaventura, Joe ^c   Irwin, David C ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hemolysis; Hemolytic; Hypoxia; Pulmonary hypertension

Indexed keywords

4 HYDROXYNONENAL; HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; NITRIC OXIDE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HEART OUTPUT; HEART RIGHT VENTRICLE HYPERTROPHY; HEMOGLOBIN BLOOD LEVEL; INFLAMMATION; LUNG ARTERY PRESSURE; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CARDIAC OUTPUT; CYCLIC N-OXIDES; HEMODYNAMICS; HEMOGLOBINS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INFUSION PUMPS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; LIPID PEROXIDATION; LUNG; LUNG DISEASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; VASCULAR DISEASES;

EID: 84865129051     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00074.2012     Document Type: Article

References (24)

1. Blood AB, Schroeder HJ, Terry MH, Merrill-Henry J, Bragg SL, Vrancken K, Liu T, Herring JL, Sowers LC, Wilson SM, Power GG. Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation. Circulation 123: 605-612, 2011.
2. Buehler P, D'Agnillo F. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid Redox Signal 12: 275-291, 2010.
3. Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, Ware RE. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116: 687-692, 2010.
4. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000.
5. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86: 1224-1229, 2000.
6. Conover CD, Linberg R, Lejeune L, Nagy M, Shum KL. PEGhemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat. Artif Organs 23: 1088-1098, 1999.
7. Crosswhite P, Sun Z. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 28: 201-212, 2011.
8. D'Agnillo F, Alayash AI. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 98: 3315-3323, 2001.
9. Giulivi C, Davies KJ. Hydrogen peroxide-mediated ferrylhemoglobin generation in vitro and in red blood cells. Methods Enzymol 231: 490-496, 1994.
10. Gladwin M, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med 359: 2254-2265, 2008.
11. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 2005: 51-57, 2005.
12. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, Russo A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res 52: 1750-1753, 1992.
13. Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol 86: 123-154, 2011.
14. Highsmith FA, Driscoll CM, Chung BC, Chavez MD, Macdonald VW, Manning JM, Lippert LE, Berger RL, Hess JR. An improved process for the production of sterile modified haemoglobin solutions. Biologicals 25: 257-268, 1997.
15. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109: 3088-3098, 2007.
16. Hu W, Jin R, Zhang J, You T, Peng Z, Ge X, Bronson RT, Halperin JA, Loscalzo J, Qin X. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood 116: 1613-1622, 2010.
17. Irwin DC, McCord JM, Nozik-Grayck E, Beckly G, Foreman B, Sullivan T, White M, Crossno JJ T, Bailey D, Flores SC, Majka S, Klemm D, van Patot MC. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 47: 55-61, 2009.
18. Kato G, Taylor J. Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Hematol: 1-12, 2009.
19. Kato GJ. Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I. Hematology Am Soc Hematol Educ Program 2008: 186-192, 2008.
20. Kato GJ, Onyekwere OC, Gladwin MT. Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol 24: 159-170, 2007.
21. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Godecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35: 790-796, 2003.
22. Klemm DJ, Majka SM, Crossno JTJr, Psilas JC, Reusch JE, Garat CV. Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 58: 181-191, 2011.
23. Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 271: 26018-26025, 1996.
24. Lardinois OM, Maltby DA, Medzihradszky KF, de Montellano PR, Tomer KB, Mason RP, Deterding LJ. Spin scavenging analysis of myoglobin protein-centered radicals using stable nitroxide radicals: characterization of oxoammonium cation-induced modifications. Chem Res Toxicol 22: 1034-1049, 2009.